Chemicals · Founded 1973 · www.amines.com · BSE 506248 · NSE AMINES&PLAST · ISIN INE275D01022
No Notes Added Yet
Business
Amines & Plasticizers Ltd. (AMNPLST) is an Indian chemical company primarily engaged in the manufacturing of specialty chemicals. Its core business revolves around producing Amines, which are organic compounds used as intermediates in various industries such as pharmaceuticals, agrochemicals, dyes, and specialty polymers. The company also manufactures Plasticizers, which are additives used to increase the plasticity or fluidity of a material, predominantly polymers (plastics), making them more flexible and easier to process. The company's business model involves large-scale chemical synthesis and sales of these intermediates to a diverse customer base in manufacturing sectors. It makes money by selling its manufactured products, deriving revenue from the volume and value of these chemical sales.
Revenue Mix
Based on its name and operations, the company's primary business segments are likely:
Amines: Manufacturing and sale of various types of amines.
Plasticizers: Manufacturing and sale of different grades of plasticizers.
Specific revenue contribution percentages for each segment are not publicly available in the provided information.
Industry
Amines & Plasticizers Ltd. operates within the broader Indian Chemicals sector, specifically in the specialty chemicals and chemical intermediates industry. This industry is characterized by its capital-intensive nature, process complexity, and exposure to raw material price volatility. The market for amines and plasticizers in India includes a mix of domestic producers and imports. AMNPLST is likely a mid-sized player, positioning itself by focusing on specific grades of amines and plasticizers required by downstream industries. Competition comes from larger domestic chemical conglomerates, other specialized manufacturers, and international players. The industry's structure often involves long-term customer relationships due to product specifications and quality requirements.
MOAT
Without specific details, AMNPLST's competitive advantages are likely modest but could include:
Operational Efficiency: Established manufacturing processes and cost-effective production in its niche.
Customer Relationships: Long-standing relationships with key industrial customers due to consistent product quality and reliable supply.
Product Specialization: Expertise in producing specific grades of amines and plasticizers that meet particular industry standards.
Regulatory Compliance & Licenses: Adherence to stringent environmental and safety regulations for chemical production, which can act as a barrier to entry for new players.
A strong, wide moat like a powerful brand or extensive network effects is less typical for a chemical intermediate producer, but incremental advantages can be built through process patents or superior R&D.
Growth Drivers
Key factors that can drive growth for Amines & Plasticizers Ltd. over the next 3-5 years include:
Growth in Downstream Industries: Increased demand from end-user sectors such as pharmaceuticals, agrochemicals, plastics, automotive, infrastructure, and paints, driven by overall economic development in India.
"Make in India" Initiative: Government focus on boosting domestic manufacturing could reduce reliance on chemical imports and favor local producers.
Capacity Expansion & Product Diversification: Investment in increasing production capacity or introducing new, higher-value specialty chemicals.
Export Opportunities: Tapping into global markets for specialized chemical intermediates.
Infrastructure Development: Increased use of plastics and construction materials drives demand for plasticizers.
Risks
Raw Material Price Volatility: The prices of crude oil derivatives and other chemical feedstocks, which are key raw materials, can fluctuate significantly, impacting production costs and margins.
Cyclicality of Demand: Demand for chemicals is often linked to the broader economic cycle and industrial output, making the company susceptible to economic downturns.
Intense Competition: The presence of larger domestic and international players can lead to pricing pressure and market share erosion.
Regulatory & Environmental Risks: Strict and evolving environmental regulations, safety standards, and hazardous waste disposal norms can increase operational costs and compliance burdens.
Technological Obsolescence: Emergence of new manufacturing processes or substitute products could impact the relevance of existing product lines.
Currency Fluctuations: For companies involved in imports of raw materials or exports of finished products, currency volatility can impact profitability.
Management & Ownership
Amines & Plasticizers Ltd. is likely a promoter-driven company, a common structure in India, where the founding family or a group of promoters holds a significant stake and plays a key role in management and strategic decision-making. The management team likely comprises individuals with experience in the chemical industry, focusing on operational efficiency and market expansion. The ownership structure typically involves a substantial promoter holding, alongside institutional investors and public shareholders. Detailed information on specific management quality assessments or current ownership percentages is not provided.
Outlook
Amines & Plasticizers Ltd. operates in essential chemical segments crucial for various manufacturing industries. Its growth trajectory is intrinsically linked to the overall industrial and economic growth of India. The company faces a dynamic market influenced by raw material price volatility and competition. The bull case hinges on robust demand from downstream sectors, successful capacity utilization or expansion, and effective cost management. The bear case would involve sustained high raw material costs, intense pricing pressure from competitors, and potential slowdowns in key end-user industries. Overall, AMNPLST is positioned to benefit from India's industrial growth, provided it can effectively navigate the inherent cyclicality and competitive pressures of the chemical industry through operational efficiency and strategic market positioning.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 177 | 137 | 167 | 191 | 166 | 140 | 133 | 142 | 155 | 151 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 177 | 138 | 167 | 191 | 166 | 140 | 133 | 143 | 155 | 151 |
| Total Expenditure | 155 | 123 | 150 | 174 | 145 | 127 | 122 | 130 | 132 | 136 |
| Operating Profit | 22 | 15 | 17 | 17 | 21 | 13 | 11 | 13 | 24 | 15 |
| Interest | 3 | 2 | 2 | 3 | 3 | 2 | 1 | 1 | 2 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 17 | 12 | 13 | 13 | 17 | 10 | 8 | 11 | 21 | 13 |
| Provision for Tax | 5 | 3 | 3 | 3 | 4 | 3 | 2 | 3 | 5 | 3 |
| Profit After Tax | 13 | 9 | 10 | 10 | 13 | 7 | 6 | 8 | 15 | 9 |
| Adjustments | 0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Profit After Adjustments | 13 | 9 | 10 | 10 | 13 | 7 | 6 | 8 | 15 | 9 |
| Adjusted Earnings Per Share | 2.4 | 1.6 | 1.8 | 1.8 | 2.3 | 1.4 | 1.1 | 1.4 | 2.8 | 1.7 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 262 | 295 | 326 | 455 | 399 | 442 | 563 | 597 | 647 | 661 | 571 | 581 |
| Other Income | 0 | 1 | 4 | 3 | 4 | 5 | 5 | 3 | 3 | 1 | 1 | 0 |
| Total Income | 263 | 296 | 331 | 458 | 403 | 447 | 568 | 600 | 650 | 662 | 572 | 582 |
| Total Expenditure | 239 | 267 | 298 | 421 | 357 | 389 | 523 | 555 | 578 | 592 | 511 | 520 |
| Operating Profit | 24 | 30 | 33 | 36 | 46 | 58 | 45 | 45 | 72 | 70 | 60 | 63 |
| Interest | 8 | 6 | 7 | 8 | 9 | 10 | 9 | 10 | 13 | 10 | 5 | 5 |
| Depreciation | 2 | 2 | 3 | 3 | 3 | 4 | 4 | 5 | 5 | 6 | 6 | 4 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | -3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 14 | 21 | 23 | 26 | 30 | 44 | 32 | 30 | 54 | 55 | 49 | 53 |
| Provision for Tax | 5 | 6 | 8 | 9 | 6 | 11 | 8 | 7 | 14 | 14 | 13 | 13 |
| Profit After Tax | 9 | 15 | 15 | 16 | 25 | 33 | 24 | 23 | 40 | 41 | 37 | 38 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 9 | 15 | 15 | 16 | 25 | 33 | 24 | 23 | 40 | 41 | 37 | 38 |
| Adjusted Earnings Per Share | 1.6 | 2.7 | 2.7 | 3 | 4.5 | 5.9 | 4.3 | 4.2 | 7.2 | 7.5 | 6.6 | 7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -14% | -1% | 5% | 8% |
| Operating Profit CAGR | -14% | 10% | 1% | 10% |
| PAT CAGR | -10% | 17% | 2% | 15% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -24% | 4% | 6% | 19% |
| ROE Average | 13% | 17% | 16% | 21% |
| ROCE Average | 17% | 20% | 19% | 22% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 41 | 55 | 68 | 82 | 108 | 141 | 162 | 183 | 220 | 259 | 292 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 21 | 21 | 23 | 32 | 29 | 27 | 26 | 23 | 22 | 11 | 12 |
| Other Non-Current Liabilities | 5 | 6 | 7 | 7 | 6 | 7 | 7 | 8 | 9 | 9 | 9 |
| Total Current Liabilities | 72 | 79 | 92 | 130 | 88 | 130 | 115 | 131 | 139 | 138 | 109 |
| Total Liabilities | 140 | 161 | 190 | 252 | 232 | 305 | 310 | 344 | 389 | 416 | 422 |
| Fixed Assets | 35 | 36 | 40 | 43 | 75 | 73 | 84 | 80 | 80 | 80 | 76 |
| Other Non-Current Assets | 13 | 19 | 22 | 35 | 8 | 15 | 6 | 8 | 6 | 4 | 5 |
| Total Current Assets | 91 | 106 | 128 | 174 | 149 | 217 | 220 | 256 | 303 | 332 | 342 |
| Total Assets | 140 | 161 | 190 | 252 | 232 | 305 | 310 | 344 | 389 | 416 | 422 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 1 | 1 | 5 | 10 | 2 | 46 | 3 | 6 | 36 | 42 |
| Cash Flow from Operating Activities | 14 | 9 | 22 | 10 | 31 | 44 | -27 | 5 | 47 | 29 | 66 |
| Cash Flow from Investing Activities | -1 | -5 | -4 | -16 | -17 | -6 | -4 | -2 | -1 | -3 | -1 |
| Cash Flow from Financing Activities | -13 | -5 | -14 | 12 | -22 | 6 | -13 | 0 | -16 | -20 | -58 |
| Net Cash Inflow / Outflow | -1 | 0 | 4 | 6 | -8 | 44 | -43 | 3 | 30 | 6 | 7 |
| Closing Cash & Cash Equivalent | 1 | 1 | 5 | 10 | 2 | 46 | 3 | 6 | 36 | 42 | 49 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 1.64 | 2.69 | 2.68 | 2.99 | 4.47 | 5.92 | 4.34 | 4.16 | 7.24 | 7.45 | 6.64 |
| CEPS(Rs) | 2.05 | 3.11 | 3.15 | 3.48 | 5.01 | 6.67 | 5.13 | 5.04 | 8.17 | 8.46 | 7.67 |
| DPS(Rs) | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 |
| Book NAV/Share(Rs) | 7.19 | 10.06 | 12.37 | 14.89 | 19.65 | 25.58 | 29.49 | 33.2 | 40 | 47.01 | 53.12 |
| Core EBITDA Margin(%) | 8.26 | 8.84 | 8.5 | 7.44 | 10.44 | 11.95 | 7.13 | 7.11 | 10.68 | 10.45 | 10.47 |
| EBIT Margin(%) | 7.62 | 8.58 | 9.02 | 7.42 | 9.96 | 12.12 | 7.28 | 6.76 | 10.31 | 9.79 | 9.6 |
| Pre Tax Margin(%) | 4.83 | 6.58 | 6.87 | 5.67 | 7.61 | 9.94 | 5.71 | 5.07 | 8.29 | 8.31 | 8.65 |
| PAT Margin (%) | 3.21 | 4.61 | 4.41 | 3.61 | 6.16 | 7.38 | 4.24 | 3.83 | 6.16 | 6.21 | 6.4 |
| Cash Profit Margin (%) | 4 | 5.33 | 5.18 | 4.2 | 6.91 | 8.31 | 5.02 | 4.64 | 6.95 | 7.05 | 7.39 |
| ROA(%) | 6.51 | 9.83 | 8.4 | 7.43 | 10.18 | 12.15 | 7.76 | 6.99 | 10.86 | 10.18 | 8.71 |
| ROE(%) | 25.32 | 31.19 | 23.92 | 21.91 | 25.89 | 26.2 | 15.75 | 13.26 | 19.78 | 17.13 | 13.26 |
| ROCE(%) | 22.29 | 25.78 | 25.45 | 23.88 | 24.33 | 28.16 | 18.26 | 16.1 | 23.3 | 20.19 | 16.73 |
| Receivable days | 51.21 | 47.47 | 48.38 | 48.4 | 66.33 | 64.98 | 61.98 | 68.37 | 61.88 | 64.14 | 87.42 |
| Inventory Days | 43.39 | 39.77 | 53.02 | 46.11 | 53.07 | 46.76 | 45.48 | 49.45 | 46.41 | 48.19 | 53.78 |
| Payable days | 66.8 | 65.18 | 76.54 | 73.02 | 89.59 | 85.95 | 62.72 | 53.3 | 54.55 | 51.84 | 59.09 |
| PER(x) | 10.19 | 14.82 | 21.55 | 11.13 | 4.47 | 12.9 | 25.2 | 16.82 | 22.83 | 28.74 | 20.48 |
| Price/Book(x) | 2.33 | 3.96 | 4.67 | 2.23 | 1.02 | 2.99 | 3.7 | 2.11 | 4.13 | 4.56 | 2.56 |
| Dividend Yield(%) | 1.19 | 0.75 | 0.52 | 0.9 | 1.5 | 0.52 | 0.37 | 0.71 | 0.3 | 0.23 | 0.37 |
| EV/Net Sales(x) | 0.56 | 0.93 | 1.12 | 0.55 | 0.41 | 1.01 | 1.19 | 0.77 | 1.48 | 1.83 | 1.27 |
| EV/Core EBITDA(x) | 6.24 | 9.23 | 11.16 | 6.81 | 3.58 | 7.73 | 14.71 | 10.18 | 13.29 | 17.22 | 11.94 |
| Net Sales Growth(%) | -13.13 | 12.49 | 10.66 | 39.42 | -12.29 | 10.71 | 27.44 | 6.06 | 8.33 | 2.12 | -13.58 |
| EBIT Growth(%) | 5.47 | 27.99 | 9.62 | 12.02 | 17.64 | 34.76 | -23.5 | -1.4 | 65.07 | -2.97 | -15.28 |
| PAT Growth(%) | 44.06 | 63.62 | -0.29 | 11.35 | 49.71 | 32.49 | -26.8 | -4.13 | 74.13 | 2.95 | -10.9 |
| EPS Growth(%) | 44.06 | 63.61 | -0.29 | 11.35 | 49.71 | 32.49 | -26.8 | -4.13 | 74.13 | 2.95 | -10.9 |
| Debt/Equity(x) | 1.5 | 1.07 | 0.8 | 0.96 | 0.54 | 0.52 | 0.44 | 0.46 | 0.39 | 0.3 | 0.09 |
| Current Ratio(x) | 1.26 | 1.35 | 1.4 | 1.34 | 1.68 | 1.67 | 1.91 | 1.96 | 2.18 | 2.41 | 3.12 |
| Quick Ratio(x) | 0.83 | 0.86 | 0.76 | 0.9 | 1.01 | 1.25 | 1.16 | 1.38 | 1.54 | 1.79 | 2.36 |
| Interest Cover(x) | 2.73 | 4.3 | 4.2 | 4.22 | 4.24 | 5.57 | 4.65 | 4 | 5.1 | 6.59 | 10.04 |
| Total Debt/Mcap(x) | 0.64 | 0.27 | 0.17 | 0.43 | 0.53 | 0.18 | 0.12 | 0.22 | 0.09 | 0.07 | 0.04 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 73.17 | 73.17 | 73.17 | 73.17 | 73.17 | 73.17 | 73.17 | 73.17 | 73.17 | 73.17 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 26.83 | 26.83 | 26.83 | 26.83 | 26.83 | 26.83 | 26.83 | 26.83 | 26.83 | 26.83 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 4.03 | 4.03 | 4.03 | 4.03 | 4.03 | 4.03 | 4.03 | 4.03 | 4.03 | 4.03 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 1.48 | 1.48 | 1.48 | 1.48 | 1.48 | 1.48 | 1.48 | 1.48 | 1.48 | 1.48 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -14% | -1% | +5% | +8% |
| Operating Profit CAGR | -14% | +10% | +1% | +10% |
| PAT CAGR | -10% | +17% | +2% | +15% |
| Share Price CAGR | -24% | +4% | +6% | +19% |
| ROE Average | +13% | +17% | +16% | +21% |
| ROCE Average | +17% | +20% | +19% | +22% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 73.17 | 73.17 | 73.17 | 73.17 | 73.17 | 73.17 | 73.17 | 73.17 | 73.17 | 73.17 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 26.83 | 26.83 | 26.83 | 26.83 | 26.83 | 26.83 | 26.83 | 26.83 | 26.83 | 26.83 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 4.03 | 4.03 | 4.03 | 4.03 | 4.03 | 4.03 | 4.03 | 4.03 | 4.03 | 4.03 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 1.48 | 1.48 | 1.48 | 1.48 | 1.48 | 1.48 | 1.48 | 1.48 | 1.48 | 1.48 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.